Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,264.00
Bid: 12,280.00
Ask: 12,282.00
Change: 146.00 (1.20%)
Spread: 2.00 (0.016%)
Open: 12,244.00
High: 12,384.00
Low: 12,228.00
Prev. Close: 12,118.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Stocks in red amid sticky US inflation data

Tue, 13th Feb 2024 16:53

(Alliance News) - Stock prices in London closed in the red on Tuesday, after a key US inflation reading came in hotter-than-expected.

The FTSE 100 index closed down 61.41 points, 0.8%, at 7,512.28. The FTSE 250 ended down 280.10 points, 1.5%, at 18,923.83, and the AIM All-Share closed down 2.85 points, 0.4%, at 747.33.

The Cboe UK 100 ended down 0.9% at 750.56, the Cboe UK 250 closed down 1.7% at 16,341.91, and the Cboe Small Companies ended down 0.2% at 14,364.40.

In European equities on Tuesday, the CAC 40 in Paris and the DAX 40 in Frankfurt both closed down 0.9%.

Stocks in New York were lower at the London equities close, with the DJIA down 1.1%, the S&P 500 index down 1.0%, and the Nasdaq Composite down 1.2%.

The US inflation rate cooled but at a slower pace than expected last month, key figures on Tuesday showed.

According to the Bureau of Labor Statistics, the nation's consumer price inflation rate eased to 3.1% in January, from 3.4% in December. It had been expected to ebb to 2.9%, according to FXStreet cited consensus, so the latest reading topped expectations.

Annual core inflation, so excluding food and energy, was steady at 3.9% in January, defying expectations of a slowdown to 3.7%.

"US inflation failed to moderate as hoped with housing costs, air fares, medical care and recreation all keeping the run rate for month-on-month inflation hot. Their favoured measure of inflation, the core PCE deflator, may be cooling nicely, but the mixed messages means the Fed can't relax, with little inclination for imminent rate cuts," said ING's James Knightley.

The reading all but ensures that any tiny thread of hope that the Federal Reserve will cut interest rates next month were extinguished. Investors are looking to May for the first Fed cut of the year, though Tuesday's data could dampen that hope.

Ebury's Matthew Ryan said that a May cut is now "in serious jeopardy."

Ryan added: "We stand by our call for a start to the Fed's cutting cycle in June, albeit this would also be thrown in doubt should US inflation continue to surprise to the upside, while the labour market shows no signs of slowing down."

The dollar was mostly stronger on the back of the reading.

The pound was quoted at USD1.2596 at the London equities close Tuesday, down compared to USD1.2621 at the close on Monday. The euro stood at USD1.0716 at the European equities close Tuesday, down against USD1.0769 at the same time on Monday.

Against the yen, the dollar was trading at JPY150.66, higher compared to JPY149.44 late Monday.

Meanwhile, in the UK, there was also some key economic data for investors to digest.

According to the Office for National Statistics, the jobless rate faded to 3.8% in the three months to the end of December from 4.2% in the period from September to November.

Unemployment had been expected to ease slightly less, to 4.0%, according to FXStreet-cited market consensus.

Annual growth in regular earnings, so excluding bonuses, amounted to 6.2% in the three months to December. Including bonuses, earnings rose 5.8% on-year.

Pay growth was hotter than expected by both measures. Earnings including bonuses had been expected to rise by 5.6%, according to FXStreet, while excluding bonuses, a rise of 6.0% was forecast.

"Stronger than expected labour data from the UK didn't help matters as it effectively gives the Bank of England another reason to keep rates steady and not rush to cut them," AJ Bell's Russ Mould explained.

The BoE's next decision is on March 21.

On Wednesday, the ONS reports UK inflation data for January. Annual consumer price inflation is expected to have picked up to 4.2% last month from 4.0% in December, according to FXStreet.

In London, property firms were among the worst large-cap performers following the red-hot UK data.

Property portal Rightmove fell 3.0%, while housebuilders Taylor Wimpey, Persimmon, and Barratt Developments fell 4.4%, 4.1% and 4.6%.

There were just eight FTSE 100 companies in the green. Amogst them, pharmaceutical firms AstraZeneca and GSK were up 1.0% and 1.1%, respectively.

In the FTSE 250, Tui shares closed up 0.8%.

Tui's pretax loss narrowed to EUR103.1 million in the three months that ended December 31 from EUR272.6 million a year before, as revenue rose by 15% to a "record" EUR4.30 billion from EUR3.75 billion.

On London's AIM, Saietta plummeted 54%.

The Towcester, England-based manufacturer said it would be selling a redundant production line after missing out on a potentially lucrative manufacturing contract.

The company has received a proposal of GBP600,000 from an unnamed buyer for the purchase of a redundant production line at its Sunderland manufacturing site.

Saietta said that the sale is the result of the company being unable to reach a commercial agreement for a contract to product electrical steering pumps at the Sunderland plant.

Brent oil was quoted at USD82.93 a barrel at the London equities close Tuesday, up from USD81.69 late Monday.

Gold was quoted at USD1,995.88 an ounce at the London equities close Tuesday, lower against USD2,013.55 at the close on Monday.

In Wednesday's UK corporate calendar, there are full year results from Coca-Cola HBC. There are also trading statements from Severn Trent and United Utilities.

The economic calendar for Wednesday has a gross domestic product reading for the eurozone at 1000 GMT, as well as employment data.

For the UK, there are CPI and PPI readings at 0700 GMT. Further at 1500 GMT, Bank of England Governor Andrew Bailey will speak.

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved..

More News
Today 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
Today 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
Today 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
Today 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
Today 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.